AT&T, Inc. (NYSE:T) reported that its net income for the third quarter of $3B or $0.58 per share, compared to $3.8B or $0.72 a share for the year-before quarter. Excluding significant items, adjusted EPS for the third quarter was $0.63, compared to $0.66 in the prior year quarter. AT&T, Inc. (NYSE:T) has 5186.00 million outstanding shares with market capitalization of 178.9 Billion and its share price finished at $34.50 by plunging -0.35% in last traded session. As the returns are concern, return on equity was recorded 19.90% and firm increased its return on investment of 12.80% while its return on asset stayed at 6.30%.Tractor Supply Company (NASDAQ:TSCO) released that its third-quarter net income surged to $76.6M from $64.8M, previous year. EPS was $0.55 compared to $0.46 in the third quarter of the previous year. The firm 27 analysts polled by Thomson Reuters anticipated the firm to report profit per share of $0.50 for the quarter. Analysts' estimates typically exclude special items. Tractor Supply Company (NASDAQ:TSCO) shares price moved down -0.26% to close at $61.30. Its return of equity was recorded 28.00% and its return on investment was calculated 26.30%. Its 50-Day moving average was -1.13% and 200-Day moving average was -5.70%.Citrix Systems, Inc. (NASDAQ:CTXS) declared that its third-quarter net income of $48M, or $0.29 a share, compared to $77M, or $0.41 a share, for the third quarter of fiscal year 2013. GAAP results for the third quarter of fiscal year 2014 include a charge of approximately $21 million related to a previously disclosed patent lawsuit, as well as a restructuring charge of $3 million for severance costs incurred to better align resources to strategic initiatives. Non-GAAP net income for the third quarter of fiscal year 2014 was $125 million, or $0.75 per share. Citrix Systems, Inc. (NASDAQ:CTXS) after opening at $65.07 hit its intraday high price of $65.54 and finished at $64.78 with shares moved down -1.85%.GlaxoSmithKline plc (NYSE:GSK) declared a drop in third-quarter profit, hurt by lower demand for pharmaceutical products mainly respiratory drug Advair, as well as weakness at consumer healthcare business. Glaxo as well released restructuring of its pharmaceutical business, quoting pricing pressure in the respiratory business. GlaxoSmithKline plc (NYSE:GSK) finished trading at $44.41 with market capitalization of 106.7 Billion. Corporation has the current ratio of 1.10 for the most recent quarter with 52-week high price of $56.73 and its 52-week low was recorded at $41.91.






